One-liner#

Evaluate hemoptysis (coughing up blood) to identify life-threatening massive hemoptysis requiring emergent intervention, rule out lung cancer in high-risk patients, and manage common benign causes like acute bronchitis while ensuring appropriate follow-up imaging.

Quick nav#

Red flags / send to ED#

  • Massive hemoptysis: >100 mL in 24 hours OR any amount causing respiratory compromise
  • Ongoing bright red blood with each cough
  • Respiratory distress or hypoxia
  • Hemodynamic instability
  • Known or suspected lung cancer with new hemoptysis
  • Anticoagulated patient with significant hemoptysis
  • Unable to protect airway (drowning in blood)

Key history#

Confirm true hemoptysis:

  • Hemoptysis: blood originating from lower respiratory tract (coughed up)
  • Hematemesis: blood from GI tract (vomited, often with food particles, coffee-ground appearance)
  • Epistaxis with posterior drainage: blood from nose draining to throat
  • Gingival bleeding: blood from gums mixed with saliva

Quantify the bleeding:

  • Scant/blood-streaked sputum: most common; often benign
  • Mild: <30 mL/day (tablespoon = ~15 mL; teaspoon = ~5 mL)
  • Moderate: 30–100 mL/day
  • Massive: >100 mL/day or any amount causing respiratory compromise

Practical tip: Ask patient to cough into a white tissue or cup to visualize. “How many tissues soaked with blood?” or “Could you fill a shot glass?” helps quantify.

Characterize the blood:

  • Bright red: active bleeding, bronchial source
  • Dark red/brown: older blood, less acute
  • Pink frothy: pulmonary edema (not true hemoptysis)
  • Blood-streaked sputum: often bronchitis

Associated symptoms:

  • Cough: acute (bronchitis, pneumonia) vs chronic (bronchiectasis, cancer)
  • Fever: pneumonia, TB, lung abscess
  • Dyspnea: PE, pneumonia, cancer with obstruction
  • Chest pain: PE (pleuritic), pneumonia, cancer
  • Weight loss: malignancy, TB
  • Night sweats: TB, malignancy
  • Leg swelling/pain: DVT → PE

Risk factors for lung cancer (critical to assess):

  • Smoking history: pack-years (>30 pack-years = high risk)
  • Age >40 (especially >55)
  • Prior lung cancer or head/neck cancer
  • Occupational exposures: asbestos, radon, uranium
  • Family history of lung cancer
  • COPD

Risk factors for PE:

  • Immobilization, recent surgery, travel
  • Malignancy
  • Prior VTE
  • Estrogen use
  • Pregnancy/postpartum

Risk factors for TB:

  • Born in or travel to endemic area
  • HIV or immunocompromised
  • Homeless, incarcerated, congregate living
  • Healthcare worker
  • Close contact with active TB

Medication review:

  • Anticoagulants: warfarin, DOACs, heparin (increase bleeding risk)
  • Antiplatelets: aspirin, clopidogrel
  • Cocaine: can cause diffuse alveolar hemorrhage

Focused exam#

  • Vitals: SpO₂, RR, HR, BP, temperature
  • General: respiratory distress, cachexia (malignancy), pallor (anemia from chronic blood loss)
  • HEENT: nasal mucosa (epistaxis source), oropharynx (gingival bleeding, posterior pharynx blood)
  • Neck: lymphadenopathy (malignancy, TB)
  • Lungs: focal findings (mass, consolidation), wheezes (obstruction), crackles (pneumonia, hemorrhage)
  • Cardiac: murmurs (mitral stenosis can cause hemoptysis), irregular rhythm
  • Extremities: clubbing (lung cancer, bronchiectasis), unilateral leg swelling (DVT)
  • Skin: telangiectasias (hereditary hemorrhagic telangiectasia), petechiae (coagulopathy)

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Acute bronchitis“Cold with bloody mucus,” “coughing so hard I’m bleeding”Recent URI; blood-streaked sputum; self-limitedNormal or mild rhonchi; no focal findingsSupportive care; CXR if >1 week or risk factors
Pneumonia“Fever,” “cough,” “rusty sputum”Fever, productive cough, dyspnea; may have pleuritic painFocal crackles; feverCXR; antibiotics
COPD/chronic bronchitis“Always coughing up stuff, now some blood”Known COPD; chronic productive cough; blood-streakedDecreased breath sounds; wheezes; barrel chestCXR; CT if persistent or concerning
Bronchiectasis“Lots of mucus every day,” “recurrent infections”Chronic productive cough; recurrent pneumonias; daily sputumCrackles (often bibasilar); clubbingCT chest (HRCT)
Anticoagulation-related“On blood thinners”On warfarin/DOAC; may have supratherapeutic INROften normalCheck INR if on warfarin; CXR; assess severity
Epistaxis with aspiration“Nosebleed, then coughed up blood”History of epistaxis; blood in posterior pharynxBlood in posterior pharynx; nasal sourceTreat epistaxis; confirm no lower respiratory source

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Lung cancer“Smoker,” “losing weight,” “cough changed”Smoking history; age >40; weight loss; persistent coughClubbing; lymphadenopathy; focal lung findings; cachexiaCXR → CT chest; urgent pulmonology/oncology
Pulmonary embolism“Sudden shortness of breath,” “leg swelling”PE risk factors; acute dyspnea; pleuritic pain; hemoptysis in ~20%Tachycardia; tachypnea; hypoxia; unilateral leg swellingWells score; D-dimer or CT-PA
Tuberculosis“Night sweats,” “weight loss,” “immigrant”TB risk factors; fever, night sweats, weight loss; chronic coughCachexia; may have apical cracklesCXR; sputum AFB x 3; isolate; public health
Pulmonary vasculitis (GPA, MPA)“Bloody nose and coughing blood,” “kidney problems”Sinusitis + hemoptysis + renal involvement; systemic symptomsMay have saddle nose deformity; purpuraCXR; UA; ANCA; urgent rheumatology
Mitral stenosis“Heart murmur,” “short of breath”History of rheumatic fever; dyspnea; AFDiastolic murmur at apex; AF; signs of HFEchocardiogram; cardiology
Diffuse alveolar hemorrhage“Coughing lots of blood,” “can’t breathe”Acute dyspnea + hemoptysis + diffuse infiltrates; autoimmune disease, cocaineDiffuse crackles; hypoxia; respiratory distressCXR; bronchoscopy; ED/ICU
Lung abscess“Foul-smelling sputum,” “fever”Aspiration risk; foul sputum; fever; weight lossFever; focal findings; poor dentitionCXR → CT; antibiotics

Workup#

All patients with hemoptysis need CXR (unless clearly epistaxis or gingival source).

Initial workup:

TestWhen to orderWhat it tells you
CXRAll patients with true hemoptysisMass, infiltrate, cavity, cardiomegaly; normal in 30% of hemoptysis
CBCAll patientsAnemia (chronic blood loss); thrombocytopenia; leukocytosis (infection)
Coagulation studies (PT/INR, PTT)On anticoagulants; suspected coagulopathySupratherapeutic anticoagulation; coagulopathy
BMPBaseline; suspected renal involvement (vasculitis)Renal function
UASuspected vasculitis (pulmonary-renal syndrome)Hematuria, proteinuria, casts
Sputum cultureSuspected pneumonia or TBPathogen identification
Sputum AFB x 3TB risk factorsTB diagnosis; must collect 3 specimens

CT chest indications:

  • Abnormal CXR
  • Normal CXR but high-risk for malignancy (smoker >40, >30 pack-years)
  • Recurrent or persistent hemoptysis
  • Suspected bronchiectasis
  • Risk factors for PE (CT-PA)

Bronchoscopy indications (pulmonology referral):

  • Massive hemoptysis (after stabilization)
  • Suspected endobronchial lesion
  • Hemoptysis with normal CT (to localize source)
  • Recurrent unexplained hemoptysis
  • Suspected diffuse alveolar hemorrhage

When NOT to order extensive workup:

  • Clear acute bronchitis with blood-streaked sputum, normal CXR, low-risk patient → observe
  • Obvious epistaxis source with no respiratory symptoms

Risk stratification for malignancy:

High-risk features (warrant CT even if CXR normal):

  • Age >40 and smoking history >30 pack-years
  • Hemoptysis >1 week
  • Weight loss
  • Prior malignancy
  • Abnormal lung exam

Low-risk features (may observe with close follow-up):

  • Age <40, non-smoker
  • Blood-streaked sputum with acute bronchitis
  • Normal CXR
  • Resolves with treatment of underlying cause

Initial management#

Massive hemoptysis (>100 mL or respiratory compromise):

  • Call 911 / send to ED immediately
  • Position patient with bleeding side down (if known) to protect good lung
  • Supplemental O₂
  • Large-bore IV access if available
  • Do NOT attempt to manage in office

Non-massive hemoptysis:

  1. Assess severity and stability
  2. Obtain CXR
  3. Treat underlying cause
  4. Determine need for CT and/or pulmonology referral
  5. Ensure appropriate follow-up

Anticoagulation management:

  • If supratherapeutic INR: hold warfarin, consider vitamin K
  • If therapeutic anticoagulation with minor hemoptysis: usually continue; treat underlying cause
  • If significant hemoptysis: hold anticoagulation, discuss with prescribing physician, assess risk/benefit
  • DOAC reversal agents (idarucizumab, andexanet) rarely needed in outpatient setting

Cough suppression:

  • May reduce hemoptysis by reducing airway trauma
  • Benzonatate 100–200 mg TID
  • Dextromethorphan 10–20 mg Q4H
  • Codeine 10–20 mg Q4–6H (if severe, short-term)

Management by diagnosis#

Acute Bronchitis with Hemoptysis#

Education:

  • Blood-streaked sputum common with severe coughing
  • Airway inflammation and trauma from coughing causes minor bleeding
  • Self-limited; resolves as bronchitis improves
  • No antibiotics needed (viral cause)

Treatment:

  • Supportive care: rest, hydration
  • Cough suppression if severe
  • No antibiotics (unless bacterial pneumonia suspected)
DrugDoseContraindicationsMonitoringCostNotes
Benzonatate100–200 mg TIDHypersensitivityNone$Cough suppression; do not chew
Dextromethorphan10–20 mg Q4H PRNMAOIsNone$OTC cough suppressant

Follow-up: Should resolve within 1–2 weeks. If hemoptysis persists >2–3 weeks or worsens, obtain CT chest.


Pneumonia with Hemoptysis#

Education:

  • “Rusty” or blood-tinged sputum can occur with bacterial pneumonia
  • Treat the pneumonia; hemoptysis resolves with infection
  • Persistent hemoptysis after treatment warrants further evaluation

Treatment:

  • Antibiotics per CAP guidelines (see Cough Acute page)
  • Supportive care

Follow-up: CXR at 6–8 weeks to confirm resolution (especially if smoker or age >50). If hemoptysis persists after treatment, CT chest.


Lung Cancer#

Recognition:

  • Hemoptysis in smoker >40 years old = lung cancer until proven otherwise
  • Associated features: weight loss, persistent cough, dyspnea, chest pain
  • CXR may show mass, but can be normal (CT more sensitive)

PCP role:

  • Order CXR → CT chest if abnormal or high clinical suspicion
  • Urgent pulmonology/oncology referral
  • Do not delay workup

Workup:

  • CT chest with contrast
  • PET-CT for staging
  • Tissue diagnosis (bronchoscopy, CT-guided biopsy, or surgical)

Follow-up: Expedited referral to pulmonology/oncology. PCP coordinates care and manages comorbidities.


Pulmonary Embolism#

Recognition:

  • Hemoptysis occurs in ~20% of PE
  • Acute dyspnea + pleuritic chest pain + PE risk factors
  • May have unilateral leg swelling (DVT)

PCP role:

  • Calculate Wells score
  • If PE likely or D-dimer positive: send to ED for CT-PA
  • Do not start anticoagulation before confirming diagnosis (unless very high suspicion and delay to imaging)

Follow-up: After diagnosis and anticoagulation initiation, PCP manages long-term anticoagulation (minimum 3 months).


Tuberculosis#

Recognition:

  • Chronic cough + hemoptysis + fever + night sweats + weight loss
  • TB risk factors: immigrant from endemic area, HIV, homeless, incarcerated, healthcare worker
  • CXR: upper lobe infiltrates, cavities, lymphadenopathy

PCP role:

  • High suspicion → isolate patient (airborne precautions)
  • Order CXR
  • Collect sputum AFB x 3 (ideally early morning specimens on 3 different days)
  • Notify public health
  • Refer to TB clinic or infectious disease

Do NOT:

  • Start empiric TB treatment without specialist guidance
  • Send patient home without isolation instructions if TB suspected

Follow-up: Public health and ID/TB clinic manage treatment. PCP coordinates care.


Bronchiectasis#

Education:

  • Permanent airway dilation with impaired mucus clearance
  • Chronic productive cough with recurrent infections
  • Hemoptysis from inflamed, friable airways
  • Requires CT chest (HRCT) for diagnosis

Treatment:

  • Airway clearance: chest physiotherapy, flutter valve
  • Treat exacerbations with antibiotics (often Pseudomonas coverage needed)
  • Pulmonology referral for management

Follow-up: Pulmonology co-management. Monitor for exacerbations.


Education:

  • Anticoagulation increases bleeding risk but hemoptysis still warrants workup
  • Must rule out underlying lesion (cancer, bronchiectasis) that anticoagulation unmasked
  • Supratherapeutic anticoagulation increases risk

Management:

  • Check INR if on warfarin
  • Assess severity of hemoptysis
  • CXR (and often CT) to evaluate for underlying cause
  • Minor hemoptysis with therapeutic anticoagulation: usually continue anticoagulation, treat underlying cause
  • Significant hemoptysis: hold anticoagulation, discuss with prescribing physician
DrugDoseContraindicationsMonitoringCostNotes
Vitamin K (phytonadione)2.5–5 mg PO (for elevated INR)NoneINR in 24–48h$For supratherapeutic INR; PO preferred for non-emergent

Follow-up: Recheck INR. CT chest if not already done. Reassess anticoagulation indication and risk/benefit.

Follow-up#

Default intervals:

  • Acute bronchitis with hemoptysis: return if not resolved in 2–3 weeks
  • After CT showing no malignancy: pulmonology follow-up if recurrent
  • Abnormal imaging: expedited specialist referral

Imaging follow-up:

  • Normal CXR in low-risk patient: observe; CT if hemoptysis persists >2–3 weeks
  • Normal CXR in high-risk patient (smoker >40): CT chest
  • Abnormal CXR: CT chest
  • Normal CT: pulmonology referral if hemoptysis recurrent or unexplained

Referral thresholds:

  • Pulmonology: abnormal CT, recurrent/unexplained hemoptysis, suspected bronchiectasis, need for bronchoscopy
  • Oncology: suspected or confirmed lung cancer
  • Infectious disease: suspected TB
  • Hematology: coagulopathy

Return precautions:

  • Coughing up more blood or large amounts of blood
  • Blood with every cough
  • Difficulty breathing
  • Chest pain
  • Feeling faint or dizzy
  • Fever (if not already present)

Patient instructions#

  • Coughing up blood can be alarming, but small amounts of blood-streaked mucus with a bad cough are often not serious.
  • We need to find out why you are coughing up blood. A chest X-ray is the first step, and you may need additional tests.
  • If you smoke, this is an important reason to quit. Smoking is the leading cause of lung cancer.
  • Take any prescribed medications as directed.
  • Seek emergency care immediately if you cough up a large amount of blood (more than a few tablespoons), have trouble breathing, or feel faint.
  • Keep your follow-up appointments so we can make sure the bleeding has stopped and there is no serious cause.

Smartphrase snippets#

.HEMOPTYSISLOWRISK Hemoptysis with blood-streaked sputum in setting of acute bronchitis. Low risk for malignancy (age <40, non-smoker, no weight loss). CXR [normal / obtained, pending]. Plan: supportive care, cough suppression PRN. Return if hemoptysis persists >2–3 weeks, increases in amount, or new symptoms develop.

.HEMOPTYSISHIGHRISK Hemoptysis in [smoker / age >40 / with weight loss]. CXR [shows X / normal but high clinical suspicion]. Ordering CT chest to evaluate for malignancy. Discussed importance of follow-up. Will expedite pulmonology referral if CT abnormal.

.HEMOPTYSISWORKUP Hemoptysis evaluation. CXR [result]. CT chest [ordered / shows X]. Labs: CBC [result], coags [result]. Assessment: [likely diagnosis / differential]. Plan: [treatment / referral / observation]. Discussed return precautions including increased bleeding, dyspnea, or chest pain.